Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 30% ± 21% | |
intestine | 6 studies | 22% ± 6% | |
peripheral blood | 5 studies | 35% ± 11% | |
placenta | 4 studies | 39% ± 15% | |
pancreas | 3 studies | 30% ± 7% | |
uterus | 3 studies | 41% ± 18% | |
breast | 3 studies | 28% ± 4% | |
prostate | 3 studies | 40% ± 16% | |
liver | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 4891.62 | 21 / 21 | 100% | 34.33 | 504 / 504 |
esophagus | 100% | 7165.65 | 1445 / 1445 | 100% | 25.48 | 183 / 183 |
prostate | 100% | 6951.10 | 245 / 245 | 100% | 69.05 | 502 / 502 |
stomach | 100% | 4337.42 | 359 / 359 | 100% | 26.55 | 286 / 286 |
breast | 100% | 13942.29 | 459 / 459 | 100% | 32.47 | 1117 / 1118 |
intestine | 100% | 4687.57 | 966 / 966 | 100% | 28.16 | 526 / 527 |
uterus | 100% | 3722.30 | 170 / 170 | 100% | 31.63 | 458 / 459 |
ovary | 100% | 2991.41 | 180 / 180 | 100% | 24.04 | 429 / 430 |
thymus | 100% | 3292.66 | 651 / 653 | 100% | 17.97 | 602 / 605 |
kidney | 100% | 3433.91 | 89 / 89 | 99% | 16.37 | 892 / 901 |
lung | 99% | 3146.52 | 571 / 578 | 100% | 22.97 | 1155 / 1155 |
liver | 100% | 3830.36 | 226 / 226 | 98% | 16.08 | 398 / 406 |
pancreas | 95% | 2192.84 | 313 / 328 | 99% | 23.96 | 177 / 178 |
adrenal gland | 100% | 2877.96 | 258 / 258 | 95% | 20.75 | 218 / 230 |
skin | 100% | 6657.69 | 1809 / 1809 | 67% | 6.18 | 317 / 472 |
brain | 69% | 1245.11 | 1810 / 2642 | 64% | 6.06 | 450 / 705 |
adipose | 100% | 15207.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 5492.37 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.25 | 1 / 1 |
blood vessel | 100% | 4454.47 | 1331 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 2607.92 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 3800.36 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 3091.51 | 753 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 7.21 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 54% | 4.73 | 43 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HEBP2 |
Protein name | Heme binding protein 2 HEBP2 protein Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) |
Synonyms | SOUL C6orf34 |
Description | FUNCTION: Can promote mitochondrial permeability transition and facilitate necrotic cell death under different types of stress conditions. . |
Accessions | ENST00000453452.1 H7C0N7 ENST00000367697.7 Q9Y5Z4 Q05DB4 Q5THN1 ENST00000448741.5 ENST00000607197.6 [Q9Y5Z4-1] C9IZA0 |